Research & Development

OUR SCIENCE

NeuroScientific Biopharmaceuticals is committed to a research and development program that is methodically planned, efficiently executed and risk aware.

The company has two lead peptide candidates:

  • EmtinB therapeutic peptide: being developed as treatment for neurodegenerative dementia and Alzheimer’s disease, and degenerative conditions of the optic nerve.
  • 15mS.A. diagnostic peptide: being developed as a diagnostic imaging agent for early-stage Alzheimer’s disease.

EMTINB – MECHANISM OF ACTION

PRODUCT PIPELINE